Medicines List
Key Medicine List Properties (see medicines-list.xlsx for more details)
Name | Mechanism | Indication | Adverse_effects |
acetylcysteine | generation of glutathione | paracetamol poisoning | nausea |
activated charcoal | adsorption of drugs in gut | increase drug elimination and reduce drug absorption | black stools |
alendronic acid | bisphosphonate | osteoporosis, Paget's disease | oesophageal reactions, abdominal pain and distension |
aluminium hydroxide | gastric acid suppresion | dyspepsia | constipation |
amiloride | diuretic, sodium channel blocker | hypertension | hyperkalaemia |
amiodarone | potassium channel blocker | anti-arrhythmic | pulmonary fibrosis; hypthyroidism; hyperthyroidism |
amitriptyline | amine neurotransmitter uptake blocker; sodium channel blocker | anti-depressant | dry mouth; urinary retention |
amphetamine | amine neurotransmitter release | (none) | hypertension; tachycardia |
andexanet | binding to rivaroxaban or apixaban | rivaroxaban or apixaban overdose | none reported |
arsenic | inhibition of pyruvate dehyrogenase | (none) | vomiting; encephalopathy; death |
aspirin | reduces prostaglandin production by inhibiting cyclo-oxygenase | prevention of cardiovascular events | bleeding |
atenolol | beta adrenoceptor antagonist | hypertension, angina, cardiac arrhthymias | Bronchospasm |
atropine | muscarinic antagonist | (none) | dry mouth; urinary retention |
benzylpenicillin | antibacterial | bacterial infections | hypersensitivity; anaemia; leucopenia; thrombocytopenia |
benzylpiperazine (BZP) | amine neurotransmitter release | (none) | hypertension; tachycardia |
bevacizumab | binds vascular endothelial growth factor | cancer | bleeding, hypertension |
bleomycin | induces DNA breaks | cancer | pneumonitis |
busulfan | DNA cross-linking | conditioning prior to bone marrow transplant | veno-occlusive disease |
caffeine | adenosine receptor antagonist; phosphodiesterase inhibitor | respiratory stimulant | nausea; tachycardia,sleeplessness |
carbamazepine | sodium channel blocker | seizures | CNS symptoms |
carbon monoxide | binding to haemoglobin | (none) | death |
chloroquine | inhibits the parasitic enzyme heme polymerase | malaria, rheumatoid arthritis, discoid lupus erythematosus | hepatitis, cardiomyopathy, hallucination |
ciclosporin | calcineurin inhibitor | autoimmunity/transplantation | Too many to mention |
cilazapril | angiotensin converting enzyme inhibitor | hypertension | dry cough, angiodema |
cimetidine | histamine-2 receptor antagonist | gastric acid hypersecretion | diarrhoea; constipation |
ciprofloxacin | gyrase inhibitor | bacterial infection | GI symptoms |
cisplatin | DNA cross-linking of purine bases | testicular cancer; ovarian cancer | nausea & vomiting; bone marrow suppression; peripheral neuropathy |
clonidine | alpha2-adrenoceptor agonist | hypertension | hypotension |
clopidogrel | Irreversibly inhibits ADP binding to the P2Y12 receptor on platelets | prevention of thromboembolism after percutaneous coronary intervention | bleeding |
codeine | metabolism in the liver to morphine which is a full opioid agonist | mild to moderate pain; diarrhoea; non-productive cough | respiratory depression, nausea and vomiting, constipation |
cyanide | inhibition of cytochrome C oxidase | (none) | death |
cyclophosphamide | DNA cross-linking of guanine | lymphoma | nausea & vomiting; bone marrow suppression; hair loss |
debrisoquine | prevents release of noradrenaline | antihypertensive. No longer used. Used now for phenotyping CYP2D6 | |
desferoxamine | iron chelating agent | iron overdose | nausea |
dexamethasone | antiinflammatory corticosteroid | inflammation; autoimmunity | insomnia |
dexmedetomidine | alpha2 agonist | sedation | bradycardia |
diazepam | positive allosteric modulator at GABAa receptors | anxiety | drowsiness, sedation |
diclofenac | cyclooxygenase (COX) inhibition | inflammation | gastrointestinal |
digoxin | NaK-ATPase inhibitor | atrial fibrillation | nausea; cardiac arrythmias; visual disturbance |
digoxin specific F(ab) | binding to digoxin | digoxin overdose | hypokalaemia |
doxorubicin | topoisomerase inhibitor | cancer | myelosuppression, alopecia, GI symptoms |
doxycycline | ribosomal protein synthesis inhibitor | bacterial infection | GI symptoms |
edetate disodium calcium | lead, mercury, arsenic chelating agent | lead, mercury, arsenic poisoning | nausea |
enalapril | angiotensin converting enzyme inhibitor | hypertension; heart failure | hypotension; dry cough |
ergotamine | vasoconstrictor (alpha-adrenergic?) | migraine | nausea; gangrene |
erythromycin | ribosomal protein synthesis inhibitor | bacterial infection | GI symptoms |
erythromycin | macrolide antibacterial | bacterial infections | nausea, vomiting, diarrhoea, |
ethanol | CNS function modifier | methanol poisoning | incoordination; cognitive impairment |
ethinyloestradiol/levonorgestrel | suppresses pituitary gonadotrophin release, inhibiting follicular maturation and preventing ovulation. | oral contraception | venous thromboembolism |
ethylene glycol | formation of oxalic acid | (none) | renal toxicity |
etoposide | topoisomerase inhibitor | cancer | myelosuppression, alopecia, GI symptoms |
felodipine | calcium channel blocker | hypertension, angina | flushing, headache, palpitation, dizziness, fatigue, gravitational oedema |
fenoterol | beta-2 agonist | asthma | tachycardia, tremor, headache |
fluconazole | inhibits fungal menbrane synthesis | fungal infection | GI symptoms |
flumazenil | benzodiazepine receptor antagonist | benzodiazepine overdose | nausea |
fluoxetine | selective serotonin reuptake inhibitor | depression | suicidal ideation, anxiety |
fomepizole | inhibition of alcohol dehydrogenase | ethylene glycol and methanol poisoning | headache; nausea |
frusemide | inhibits renal tubular Na re-absorption | oedema; heart failure | hypotension; hypokalaemia |
fuller's earth | adsorption of drugs in gut | increase drug elimination and reduce drug absorption | |
gefitinib | inhibits epidermal growth factor receptor | lung cancer | skin rash |
gentamicin | ribosomal protein synthesis inhibitor | sepsis | nephrotoxicity; ototoxicity |
glipizide | pancreatic beta cell stimulant of insulin release | diabetes | hypoglycaemia |
haloperidol | dopaminergic receptor antagonist | schizophrenia | extra-pyramidal signs and symptoms |
hydroxocobalamin | binding to cyanide | cyanide poisoning | none reported |
ibuprofen | cyclooxygenase (COX) inhibition | inflammation | GI symptoms |
idarucizumab F(ab) | binding to dabigatran | dabigatran overdose | none reported |
imatinib | inhibits BCR-ALK and KIT tryosine kinases | chronic myelogenous leukaemia; gastrointestinal stroma tumours | GI symptoms |
insulin | insulin replacement | diabetes | hypoglycaemia |
ipecacuhana | induction of emesis | oral poisoning | not effective for poison removal |
irinotecan | Inhibits DNA topoisomerase I and interferes with DNA replication | metastatic colorectal cancer | delayed diarrohea, neutropenia and acute cholinergic syndrome |
ketamine | NMDA antagonist | anaesthesia | hallucinations |
lidocaine | sodium channel blocker | anti-arrhythmic | dizziness; paraesthesia |
loperamide | reduces gut mobility | diarrhoea | GI symptoms |
losartan | angiotensin receptor antagonist | hypertension | hypotension, dizziness |
MDMA ("ecstasy"); 3,4-Methylenedioxymethamphetamine | amine neurotransmitter release | (none) | hypertension; tachycardia |
methanol | CNS function modifier | (none) | blindness |
methotrexate | dihydrofolate reductase inhibitor | cancer | myelosuppression, GI symptoms |
metronidazole | cysteine bearing enzyme inhibitor | bacterial infection | GI symptoms |
morphine | mu-opioid receptor agonist | analgesia | nausea; constipation; respiratory depression |
naloxone | opioid receptor antagonist | opioid overdose | nausea |
neostigmine | anti-cholinesterase | reversal of muscle relaxation | salivation; diarrhoea |
nifedipine | calcium channel blocker | hypertension | oedema, headache |
nortriptyline | inhibit NA and 5HT reuptake | depression | sedation, anticholinergic effects |
omeprazole | irreversible inhibition of the H+/K+-ATPase (proton pump) in the gastric parietal cells | gastro-oesophageal reflux disease; duodenal ulcer and gastric ulcer | nausea, vomiting, |
organophosphate | anti-cholinesterase | (none) | salivation; diarrhoea |
paclitaxel | antimicrotubule drug | cancer | myelosuppression, alopecia, GI symptoms, neurotoxicity |
pancuronium | acetylcholine receptor blockade at neuromuscular junction | anaesthesia muscle relaxation | weakness, respiratory depression |
paracetamol | POX-inhibitor? Cannabinoid receptor agonist? | analgesia; fever | hepatic damage |
paraquat | superoxide anion | (none) | pulmonary fibrosis |
PB2452 | binding to ticagrelor | ticagrelor overdose | none reported |
penicillamine | copper, mercury chelating agent | Wilson's disease; copper, mercury poisoning | nausea |
phenytoin | sodium channel blocker | anti-arrhythmic | ataxia; gingival hypertrophy |
phytomenadione (vitamin K) | warfarin antagonist | bleeding due to warfarin | hypotension; neonatal jaundice |
pralidoxime | cholinesterase re-activator | organophosphate anti-cholinesterase poisoning | nausea |
prednisone/prednisolone | anti-inflammatory corticosteroid | asthma; rheumatoid arthritis | hypertension; glucose intolerance; psychiatric disturbance |
probenecid | renal tubular blocking agent | gout, adjunct to beta lactam antibiotics treatment | GI symptoms |
propofol | GABA receptors | sedation, anaesthesia | respiratry depression, hypotension |
propranolol | beta-adrenoceptor antagonist | hypertension; angina | hypotension; bradycardia; fatigue; cold extremities |
quetiapine | dopamine and 5HT receptor antagonist | psychosis | dry mouth, dizziness, drowsiness |
ranitidine | histamine H2-receptor antagonist, | gastro-oesophageal reflux disease | diarrhoea, headache, dizziness |
remifentanil | mu opioid | analgesia | respiratry depression, itch, nausea,sedation |
rifampicin | inhibitor of bacterial RNA synthesis | tuberculosis; brucellosis | nausea, vomiting, diarrhoea, alterations of liver function, headache, dizziness, chills, fever |
salbutamol | beta-2 agonist | asthma | tachycardia, tremor, headache |
salicylate | COX inhibition | analgesia; fever | bleeding; gastrointestinal distress; tinnitus; acidosis |
simvastatin | HMG CoA reductase inhibitor | prevention of cardiovascular events | gastro-intestinal disturbances, altered liver function tests, |
spirinolactone | aldosterone receptor antagonist | hypertension | drowsiness, dizziness |
succimer | lead, mercury, arsenic chelating agent | lead, mercury, arsenic poisoning | nausea |
sunitinib | vascular tyrosine kinase inhibitor | cancer | bleeding, hypertension |
tacrolimus | calcineurin inhibitor | immunosuppressant | diarrhoea; constipation |
tamoxifen | oestrogen receptor anatagonist | breast cancer | menopausal symptons |
terfenadine | anti-histamine | None. Withdrawn | cardiac arrhythmia |
thalidomide | immunomodulatory and anti-inflammatory activity | multiple myeloma | vomiting, dry mouth, dyspepsia, constipation, bradycardia |
theophylline | adenosine receptor antagonist; phosphodiesterase inhibitor | asthma; COPD | nausea; tachycardia |
tramadol | mu receptors, spinal serotonin | analgesia | respiratory depression, nausea |
trastuzumab | human epidermal growth factor receptor 2 binding monoclonal antibody | breast cancer | infusion reactions |
verapamil | calcium channel blocker | hypertension | hypotension, dizziness |
warfarin | inhibits vitamin K epoxide reductase | oral anti-coagulant | bleeding |